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Renal functional reserve: Its significance in normal and salt depletion
conditions. The aim of this study was the evaluation, in healthy
subjects, of the renal functional reserve (RFR), that is, the GFR
increase induced by a combined infusion of amino acids (AA) and
dopamine (D), in conditions of extracellular volume depletion caused
by diuretic administration. In particular, this study was undertaken: a)
to evaluate whether and to which extent, AA + D can reverse the
functional GFR impairment induced by salt depletion, without volume
restoration; b) to study whether any relationship may be found between
the GFR in normal condition (the so-called "resting" GFR), and/or the
renal functional reserve and the GFR impairment induced by salt
depletion, in order to understand the role of both "resting" GFR and
RFR in the degree of renal dysfunction induced by salt depletion. In
control conditions the iv. infusion of AA + D significantly increased
RPF (+ 41% vs. baseline period) with a mean absolute increase of 211
mi/mm. A similar pattern was observed in GFR behavior (+ 3 1.5% with
34 mI/mm of mean absolute increase). A significant inverse exponential
relationship was observed between GFR before AA + D i.v. infusion
("resting" GFR) and renal functional reserve (P < 0.05), suggesting
that, in normal conditions, these inversely related parameters may
widely vary according to the tone of the glomerular arterioles. Follow-
ing salt depletion, we observed a variable degree of GFR impairment.
Both GFR and RPF were significantly decreased (—25.9%, P < 0.05 and
—29%, P < 0.05, respectively). The GFR impairment was mainly
caused by a significant increase in tone of glomerular arterioles presum-
ably induced by vasoactive substances (angiotensin, catecholamines) as
mirrored by the increase of both plasma renin activity (PRA) and
urinary norepinephrine (NE) excretion (+ 164% and +426%, respec-
tively, vs. control period). AA + D infusion after salt depletion
determined a striking rise of both GFR (+30 mI/mm, corresponding to
37%) and RPF (+ 193 mI/mm, corresponding to 31%) versus the baseline
study of salt depleted condition. The GFR value obtained by AA -- D
i.v. infusion in the normal condition, however, was not reached
presumably because of persistence of extracellular volume contraction,
which was confirmed by the persistence of high values of PRA and NE
urinary excretion and low values of urinary sodium excretion after AA
+ D i.v. infusion. GFR impairment due to salt depletion was directly
related to the "resting" GFR (P < 0.05) and inversely related to the
RFR (P < 0.01): the latter relationship suggests that the greater the
"resting" tone of glomerular arterioles (and consequently the value of
the RFR), the more minor the role of renal vasoconstriction in causing
the fall of GFR following salt depletion. Finally, AA + D infusion in the
salt depleted condition induced a GFR increase that is inversely related
to the GFR value obtained after salt depletion (P < 0.05). This finding
suggests that glomerular arteriolar tone influences, also in a salt
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depletion condition, the response to AA + D infusion: subjects with a
lower GFR (with a greater vasoconstriction), in fact, show a greater
increase in GFR after the infusion of these vasodilating substances.
It is well known that the healthy kidney has the ability to
increase glomerular filtration rate under particular stimuli such
as a protein load [1—5], amino acids and/or dopamine infusion
[6—il], that is, through the action of substances able to modify
the "basal" tone of renal vasculature. This effect is called
"renal functional reserve" (RFR) [1—13] and is defined as the
difference between the basal glomerular filtration rate (GFR)
(the so-called unstimulated or "resting" GFR) and the maximal
GFR induced by these stimuli; renal functional reserve reflects
the capacity of all available nephrons to achieve the maximal
degree of function by vasodilation of glomerular arterioles
[1—13].
Whether renal functional reserve plays some role in the
adaptations of renal function to processes acutely influencing
renal dynamics, such as the reduction of volume status that
occurs during salt depletion, has not been demonstrated.
Ruilope and coworkers have recently shown that the increase
of renal blood flow (RB F) and GFR induced by i.v. amino acid
(AA) infusion in healthy subjects was markedly blunted when
the same subjects were tested after sodium depletion induced
by a low salt diet [14]. However, post-depletion GFR was not
depressed versus the control period. This would indicate that
changes in dietary sodium might alter the expression of renal
functional reserve. In that study, however, renal functional
reserve was not stimulated by the concomitant administration
of dopamine (D), which can elicit a greater increase of GFR
[11]. In addition, the patients undergoing the study did not have
a controlled salt intake in basal condition, a factor potentially
influencing their "resting" GFR and, possibly, the expression
of renal functional reserve.
Thus, the role of renal functional reserve in salt depleted
states deserves further attention, since salt loss is the most
common cause of hemodynamically-mediated acute renal dys-
function in healthy subjects [15—18].
The aims of the present study were: a) to evaluate whether
renal functional reserve (evaluated by amino acids + dopamine
i.v. infusion) is still present in condition of salt depletion and, if
so, to which extent amino acids + dopamine i.v. infusion can
reverse the functional GFR impairment without plasma volume
restoration; b) to study whether any relationship exists between
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"resting" GFR or renal functional reserve and the decrease of
GFR after salt depletion, in order to understand the role of both
"resting" GFR and renal functional reserve on the degree of
renal dysfunction after salt depletion.
Methods
Subjects
The study was carried out in eleven nonvegetarian, healthy
male volunteers. Their ages ranged from 17 to 43 years (mean
age was 28 8). After giving their informed consent, the
patients were encouraged to continue their usual isocaloric diet,
whose protein content was estimated on the basis of both
urinary urea nitrogen (UUN) and multiple interviews with a
dietician to provide to each patient a personal diet to be
followed for at least two weeks before the study. Protein
content of all the diets ranged between 1.0 and 1.3 g/kg!day.
Daily sodium intake (5 g/day) was held constant and was
controlled by electrolyte urinary excretion on 24 hour samples
(flame photometry). This policy was adopted to have baseline
values of GFR reflecting the dietary habits of the patients (the
so-called "resting GFR) [19—23], but excluding any influence of
salt intake on renal functional reserve expression. No medica-
tion was given during the study.
Control studies
Effective renal plasma flow (ERPF) and GFR were deter-
mined in fasting state in the morning by measuring, simulta-
neously, para-aminohippurate (PAH) clearance and inulin (In)
clearance, respectively. All the clearance studies were per-
formed on recumbent patients. PAH (8 mg/mI) and In (12
mg/mi) were administered i.v. in a 5% glucose solution at the
constant infusion rate of 2 ml/min to maintain plasma concen-
tration of inulin at 15 to 20 mg/dl and PAH at 1.5 to 2.0 mg!dl.
An additional 5% glucose infusion (5 mI/mm) was also started to
enhance diuresis. After a 60-minute equilibration period, when
a steady state of urine flow was obtained (that is, when the
magnitude of changes in urine volume did not exceed 20% in
three consecutive periods), three control clearance periods
were performed (30 mm each).
Renal functional reserve was then evaluated during the
combined i.v. infusion of two solutions: (a) a 7.5% amino acid
solution (SolaminR, Pierrel, Italy) at an infusion rate of 4
ml/min, and (b) a dopamine solution (Revivan, 50 mg in 500 ml
of 5% glucose) delivering 2 /.Lg/min/kg body wt of the drug. The
5% glucose infusion (5 mL/min) was discontinued.
After a new 60-minute equilibration period, three further
30-minute clearances were performed.
Blood samples were drawn both at the beginning and the end
of each clearance period. Urines were collected by spontaneous
voiding for determinations of PAH and inulin concentration and
for evaluation of urinary catecholamines. Blood pressure and
heart rate were monitored every ten minutes during the study.
Salt depletion studies
Following renal functional reserve determination in control
condition, eight out eleven subjects were placed on a salt-free
diet (sodium content: about 0.5 g) and given furosemide (25
mg/die per os) for at least three days at 8 a.m. until a very low
sodium urinary concentration was achieved (<10 mmol/liter) to
simulate the condition of the early phase of prerenal acute renal
failure.
Furosemide was selected to avoid prolonged pharmacologic
effects [241 during the clearance studies because of its short
half-life [25]. All studies, in fact, were performed at least 24
hours after the last administration of the drug. Urinary sodium
was measured in a morning sample before diuretic administra-
tion. When urinary sodium was less than 10 mmol/liter, renal
dynamics were determined again with the same modalities as in
control condition (before and after amino acids + dopamine i.v.
infusion). Plasma renin activity (PRA) and urinary catechol-
amines were also evaluated to assess the stimulation of both
sympathetic nervous system and renin-angiotensin system with
respect to the control condition.
Creatinine clearance, 24-hour sodium excretion, arterial pres-
sure, body weight and heart rate were also monitored daily
during salt depletion studies. No study had to be interrupted
because of hazardous drops of creatinine clearance (greater
than 20% than the basal value).
Laboratory procedures
Plasma and urine levels of inulin and PAH were determined
by photocolorimetric methods, as previously described [261.
Urea and creatinine (by Beckman Autoanalyzers, Beckman
Instruments, Fullerton, California, USA), glucose (by glucose
oxidase method), Na and K (by Beckman flame photome-
try), and osmolality (by an osmometer, Advanced Instruments,
Needham Heights, Massachusetts, USA) were also measured.
Renal vascular resistance (RVR, mm Hg/mI/mm) was deter-
mined by the ratio between mean arterial pressure and renal
blood flow (RBF = ERPF/(1 — Ht), where Ht is hematocrit).
Urinary catecholamines (epinephrine, E, and norepinephrine,
NE) were also measured in each clearance period. Briefly, the
catecholamines were eluted with a boric acid solution and
determined fluorometrically (E + NE: 405 to 495 nnj; E: 436 to
540 nm; NE by difference) after oxidation to a trihydroxyindole
derivative [27]. Before and after AA + D infusion plasma renin
activity was also measured by radioimmunoassay method
(Sorin, Italy).
Statistical analysis
All values are reported as mean standard deviation (SD).
All the clearance data have been corrected for a body surface
area of 1.73 m2.
Analysis of variance for repeated measures and regression
analysis were used. P values less than 0.05 were considered
statistically significant.
Results
Analytical data of all the patients undergoing the study both
in control conditions and after salt depletion are represented in
Table 1 and 2, respectively. An overall comparison between the
groups is shown in Table 3. Clearance data reported in Tables
represent the mean of three consecutive periods.
Blood pressure during the control studies averaged 125
10.5/75 8.4 mm Hg, and mean hematocrit value was 43.2
1.6%. Salt depletion, induced by diuretic administration asso-
ciated with a salt-free diet, determined a significant reduction of
body weight (—2.1 kg, —2.8%, P < 0.05 vs. the control period),
which was reflected by a slight although significant rise of
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Table 1. Clinical data and results of amino acid and dopamine
infusion on GFR, ERPF and FF in normal subjects
Normal condition
Baseline AA + D
GFR ERPF GFR ERPF
Subject Age rn//mm FF rn//mm FF
TR
MA
QP
CL
AC
OV
DA
GL
BM
RA
IE
Mean
SD
26
43
29
27
23
42
26
28
19
17
31
28
8
86 503
125 474
101 444
99 448
101 514
87 402
92 572
121 577
118 724
125 438
137 501
108 509
17 90
0.17
0.26
0.22
0.22
0.19
0.21
0.16
0.21
0.16
0.28
0.27
0.21
0.04
124 745
147 690
147 708
117 493
135 758
140 862
164 799
145 649
140 988
138 522
169 708
142 720
15 140
0.16
0.21
0.20
0.23
0.17
0.16
0.20
0.22
0.14
0.26
0.24
0.20
0.04
hematocrit (44.1 1.5, P < 0.02). Blood pressure was not
affected by the decrease of body weight and remained similar as
in the control period (123 10.3/77 5.2 mm Hg). Infusion of
dopamine and amino acids did not influence arterial blood
pressure nor heart rate in any of the studies.
In the control condition, the i.v. infusion of AA + D
increased significantly ERPF (+41% vs. baseline period) with a
mean absolute increase of 211 mI/mm. A similar pattern was
observed in GFR behavior. With the combined infusion of AA
+ D, in fact, GFR increased significantly by 3 1.5%. The mean
absolute increase of GFR, which represented renal functional
reserve, was 34 ml/min. Due to the parallel changes of ERPF
and GFR, filtration fraction was not modified during AA + D
infusion (Tables 1 and 3).
Renal vascular resistances were significantly decreased
(—28%) by AA + D administration, but fractional excretion of
sodium was not affected (Table 3).
A significant exponential inverse relationship was observed
between the renal functional reserve and the GFR before AA +
D i.v. infusion (the so-called "resting" GFR) (Fig. 1). The
rationale of this relationship is reported in Appendix. No
significant correlation was observed, in control condition, be-
tween the "resting" GFR and the absolute urinary sodium
excretion (UNAV) and the fractional urinary sodium excretion
(FENa), respectively.
Following salt depletion (Tables 2 and 3), baseline GFR
significantly decreased versus the baseline GFR of control
condition (—25.9%, P < 0.05), as was ERPF (—29%, P < 0.05).
Interestingly, infusion of AA + D determined a striking rise of
both parameters (GFR, +37%, and ERPF, +31% vs. baseline
study of salt depletion period). The resulting numeric values
were similar to those observed in baseline period of control
condition. Mean absolute increase of GFR was 30 mI/mm,
whereas mean increase of ERPF was 193 ml/min. GFR value
obtained after AA + D infusion in normal condition, however,
was not reached. FE was significantly decreased during AA +
D infusion after salt depletion (Tables 2 and 3). Renal vascular
resistances (RVR), which had been significantly increased by
salt depletion (+36% vs. baseline values of control period),
Table 2. Weight loss induced by salt depletion and results of amino
acid and dopamine infusion on GFR, ERPF and FF in normal
subjects
After salt depletion
Baseline AA + D
Weight loss GFR ERPF GFR ERPF
Subject kg % mi/mm FF mi/mm FF
TR
MA
QP
CL
AC
OV
DA
GL
Mean
5D
1.8 —2.4
2.6 —3,4
2.1 —3.0
1.8 —2.8
3.6 —4.7
2.2 —3.2
1.4 —1,7
1.4 —1.9
2.1 —2.8
0.7 0.9
70 380
91 355
83 377
71 390
77 378
70 315
81 358
99 339
80 361
11 25
0.18
0.25
0.21
0.17
0.20
0.22
0.22
0.29
0.21
0.03
120 494
106 498
88 4-44
97 513
113 649
124 563
119 698
110 572
110 554
12 85
0.17
0,23
0.19
0.18
0.17
0.22
0.17
0.23
0.19
0.03
were markedly reduced by AA + D infusion (—33% vs. the
baseline values of salt depleted condition; Table 3).
Fractional urinary excretion of sodium (FeNa) was signifi-
cantly reduced after salt depletion but was not modified by AA
+ D infusion (Table 3).
After salt depletion, both plasma renin activity (PRA) and
urinary norepinephrine excretion were significantly increased
(+ 164% and +426%, respectively, vs. control period), but were
not affected by AA + D infusion (Table 4).
A direct relationship was obtained between the "resting"
GFR and GFR impairment caused by salt depletion (r —0,714,
P < 0.05; Fig. 2).
The renal functional reserve, obtained in the normal condi-
tion, showed an inverse significant correlation with the GFR
decrease induced by salt depletion (r 0.856, P < 0.01; Fig. 3).
Conversely, no correlation was found between ERPF and
RFR, GFR impairment secondary to salt depletion and basal
ERPF, ERPF decrease and body weight reduction induced by
salt depletion. Similarly no correlation was found between the
absolute value of GFR impairment and the increase of RVR.
Finally, an inverse correlation was found between the GFR
after salt depletion and the GFR increase induced by AA + D
infusion in salt depleted condition (the renal functional reserve
obtained in a salt depleted condition) (r —0.7526, P < 0.05; Fig.
4).
Serum potassium concentrations were not modified by any of
experimental protocols and glucose infusion did not alter blood
concentration of glucose (range 5.42 to 6.42 mmol/liter); glycos-
uria was absent [28]. AA + D infusion did not change plasma
osmolality.
Discussion
Our results demonstrate that in a normal condition in healthy
subjects the renal functional reserve is inversely related to the
"resting" GFR (Fig. 1); in other words, RFR is a decreasing
function of the "resting" GFR. This important observation
appears crucial to define the true significance of the renal
functional reserve. In healthy subjects the demonstration of an
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Table 3. Effects of AA +
resistances (RVR) and fra
D infusion on glomerular filtration rate (GFR), renal plasma flow (ERPF), filtration fraction (FF), renal vascular
ctional urinary excretion of sodium (FFNa) in normal condition and after salt depletion (data are mean SD)
Normal Salt depletion
Baseline AA + D Baseline AA + D
(I) (ii) (Ill) (IV)
GFR 108 17 142 isa 80 110
mi/mm
ERPF 509 90 720 l40 361 25a.b 554 85)c
mi/mm
FF 0.21 0.04 0.20 0.04 0.21 0.03 0.19 003d
RVR 0.114 0.027 0.082 o.o2o 0.155 0026a,l 0.104 0.025'
mm Hg/mi/mm
FENa% 0.87 0.14 1.13 0.32 0.24 0.4e 0.26 0.16
Ia p < 0.001 vs.
b P < 0.001 vs. II
P < 0.001 vs. IIId P < 0.05 vs. III
P < 0.01 vs. I and II
inverse correlation between "resting" GFR and renal func-
tional reserve, in fact, suggests the existence of a different basal
tone of glomerular arterioles in normal kidneys that results in a
wide variability of baseline GFR, the so-called "resting" GFR
(Table 1) [2, 19—21].
When glomerular arterioles are highly dilated (as it occurs
either spontaneously during pregnancy, or after protein inges-
tion or under the effects of vasodilating substances) GFR
increases at the expense of RFR, which progressively decreases
and finally disappears.
Thus, in healthy subjects, the absence of renal functional
reserve indicates 'hyperfiltration", that is, all nephrons are
functioning at their maximal degree.
The highest GFR value in our normal subjects, obtained by
i.v. infusion of amino acids + dopamine, is around 140 mI/mm;
this value is consistent with that suggested by ter Wee et al [11].
Under normal circumstances, "resting" GFR may physiologi-
cally widely vary between 85 ml/min and 140 ml/min, depending
on the different basal tone of glomerular arterioles. A high
"resting" GFR will be associated with a low RFR, and,
conversely, subjects with low "resting" GFR will express high
values of RFR.
That the basal tone of glomerular arterioles plays a crucial
role in determining resting GFR and, consequently, the dif-
ferent expression of renal functional reserve is indirectly con-
firmed by the direct relationship observed between the GFR
decrease after salt depletion and "resting" GFR (Fig. 2). In
other words, subjects with a lower "resting" GFR had a lesser
decrease in GFR following salt depletion whereas the subjects
with a higher "resting" GFR had a greater GFR impairment.
The greater vasodilation of functioning nephrons, presumably
present in subjects with higher "resting" GFR, seems to allow
a greater susceptibility of the kidney to the vasoactive (vaso-
constrictive) substances involved in the genesis of renal hypo-
150 perfusion following extracellular volume contraction [15—18,
35—40].
In accordance with our observation of an inverse relationship
between "resting" GFR and renal functional reserve, a signif-
icant inverse correlation was also observed between the renal
functional reserve and the degree of reduction of GFR caused
by salt depletion (Fig. 3). Thus, when salt loss was great enough
to cause GFR impairment, the patients with low "resting" GFR
(and with a high RFR) exhibited a minor impairment of renal
function.
In our study, with salt depletion, the i.v. infusion of amino
acids + dopamine increased GFR and was effective in reversing
the impairment of renal function even though it did not lead to
the values of GFR observed in the normal condition.
This result is accounted for by a direct effect of the infused
vasodilating substances on the glomerular arterioles by releas-
ing the intense renal vasoconstriction with "normalization" of
ERPF and GFR (Table 3) [15—18, 35—40].
The inverse relationship found between the GFR value
obtained after salt depletion and the GFR increase following
amino acids + dopamine i.v. infusion in salt depleted condition
(Fig. 4) demonstrates that the greater the fall of GFR, the
greater the response to vasodilating substances; this further
supports the crucial role of vasoconstriction on GFR impair-
ment by salt depletion.
In the study by Ruilope et al [14], the authors failed to
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Fig. 1. Relationship between the values of "resting" GFR and of
"rena! functional reserve" (RFR) in healthy subjects. P < 0.05;y =
12.3993e9253".
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Table 4. Effects of AA + D infusion on plasm
co
a renin activity (PRA) and norepinephrine (NE) and epinephrine
ndition and after salt depletion (data are mean SD)
(E) urinary excretion in normal
Normal Depletion
Baseline AA + D Baseline AA + D
(I) (II) (III) (IV)
PRA 4.22 1.5 4.52 1.6 11.15 l0 11.65 4.5
nglml
NE 0.033 0.04 0.072 0.04 0.192 0.09a 0.252 o.o9
sg/min
E 0.005 0.004 0.015 0.01 0.008 0.02 0.010 0.006
jsg/min
a P < 0.05 vs. I and II
65 70 75 80 85 90 95 100
GFR after salt depletion, mi/rn/n
Fig. 4. Relationship between the values of GFR after salt depletion
and the changes in GFR induced by AA + D (rena/functional reserve)
in healthy subjects after salt depletion. P < 0.05; r =
—0.7526; y =
—1.337x + 138.2.
with the findings of Ruilope et al. In our study, in fact, the
salt-depletion protocol (which consisted of daily administration
of a diuretic until there was a very low urinary sodium concen-
tration) induced a definite impairment of ERPF and GFR;
furthermore, renal functional reserve was tested in our study by
the concomitant administration of both amino acids and dopa-
mine. Dopamine, when given at dopaminergic doses (1 to 2
igIkg!min), is a potent renal vasodilating agent [29, 30] even in
conditions of salt depletion [3 1—341. Our results clearly show
that not only is renal functional reserve not abolished by salt
depletion, but, on the contrary, it is not affected at all, neither
as absolute values nor as percent change values versus the
control condition.
In spite of increase in ERPF and GFR induced by amino acids
+ dopamine infusion in the salt depleted state, urinary sodium
excretion did not significantly increase. Thus, the intense
sodium conservation which occurred after volume depletion
persisted despite correction of the renal hemodynamic changes
accompanying volume depletion. This interesting finding could
be accounted for by the persistence of volume depletion and
consequent hormonal changes (a high plasma renin activity with
a likely increased plasma aldosterone concentration) after the
amino acids + dopamine infusion (Table 3).
As mentioned, in salt depletion the maximal value of GFR
(that is, baseline value + renal functional reserve in normal
non-depleted condition) was not reached under the i.v. infusion
of amino acids + dopamine. This suggests that salt depletion
causes renal hypoperfusion and fall in GFR by two mecha-
nisms: a) a hypovolemia secondary to ECV contraction; and b)
70 80 90 100 110 120
"Resting" GFR, mi/rn/n 80
0
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-25
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—35
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—40
130 140 70-
E 60
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.2 50
a, 40
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0
Fig. 2. Relationship between the values of resting" GFR and the
changes in GFR induced by salt depletion in healthy subjects. P < 0.05;
r =
—0,7138; y = —0.373x + 16.36.
Renal functional reserve, mi/rn/n
0 10 20 30 40 50 60 70 80
0
C
-10
ci.
a)
-ci
-20
>.
Fig. 3. Relationship between the values of "rena/functional reserve"
and the changes in GFR induced by salt depletion in healthy subjects.
P < 0.01; r = 0.856; y = 0.365x + —35.46.
observe a significant increase of ERPF and GFR in salt depleted
patients during amino acid infusion. It was concluded that
amino acid infusion was unable to override the predominant
effect of renal vasoconstrictive agents; the previous administra-
tion of a converting enzyme inhibitor, in fact, re-established the
amino acid effects. Similar results are described by Slomowitz
et al in diabetic patients 4l], Our results are not comparable
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an overproduction of vasoactive substances (caused by the
hypovolemia itself) leading to renal vasoconstriction [15—18,
35—40]. The latter phenomenon can be reversed by vasodilating
drugs (such as amino acids + dopamine). Volume restoration
with ECV normalization is expected to bring to normal the renal
perfusion and consequently the renal hemodynamics.
In conclusion, taken together, our findings strongly suggest
that the renal vascular tone plays a crucial role in determining
the "resting" GFR and, consequently, the different responses
to salt depletion and to vasodilatory stimuli both in normal and
salt depletion condition.
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Appendix
The effect of AA + D infusion can be conceived as an increase of
GFR above its basal value. Therefore the "stimulated" GFR (GFRStIm
ulated) can be modelled as the sum of two parts:
GFRstimulated GFRresting + (GFRresting)
where GFRreting is the "basal" GFR and (GFRreStIOg) is the absolute
GFR increase above the "basal" GFR level.
If stimulation is "maximal", (GFRrtiOg) is the renal functional
reserve (RFR) which can be estimated by:
RFR = GFRstimulated — GFRresting
Since there is a definite "maximal" level of GFR stimulation, one can
speculate that the effect of vasodilating agents (that is, the RFR)
depends on the value of GFRrestng. So, one should expect that the value
of RFR progressively vanishes as GFRrsting increases, being zero if
GFRresiing corresponds to the maximal value obtainable for GFRstim,,
lated. Therefore, it is possible to hypothesize that the rate of increase of
GFRretting, that is (GFRreSting) or RFR, is a decreasing function of the
"basal" GFR (GFRresting). The following model can be, thus, set up:
dy
— = —kx
dx
where x = GFRresting,and y = (GFRresting) or RFR.
The solution of this equation leads to a negative exponential function:
y(x) = y(o)e_k(
To evaluate this hypothesis a linear correlation analysis of In (y)
versus In (x) was performed. The computed correlation coefficient was
—0.6365 which is significant to the 0.05 level.
The best regression line was found to be:
ln(y) = 12.3993 - 1.9253 ln(x)
So the relationship between GFRreSting and RFR can be estimated as:
y = 12.3993e19253"
The negative exponential relationship between RFR and GFRrtIng is
reported in Figure 1.
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